1.1Square channel cross section
A square-bore capillary carries the cell suspension, and opposing conductive walls establish a transverse electric field. Parallel capillaries divide the inlet flow and discharge into a common outlet.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
A square-bore capillary carries the cell suspension, and opposing conductive walls establish a transverse electric field. Parallel capillaries divide the inlet flow and discharge into a common outlet.
Two parallel metal strips run along the floor in the flow direction. Voltage across the strips produces a fringing field, and a sheath stream guides cells through the region just above the gap.
Two annular electrodes are spaced along a straight insulating bore, with open centers for the suspension to pass through. A voltage difference between the rings creates an axial field in the intervening liquid.
A transistor switch connects the electrode pair to a direct-current supply during each pulse and brings both electrodes to the same potential between pulses. The pulses transiently permeabilize cell membranes so a dissolved fluorescent tracer enters from the surrounding liquid.
A digital timer holds the higher voltage level for one interval and the lower level for an interval of the same length. A bridge circuit reverses both voltage levels on the next segment, giving adjacent segments equal and opposite voltage integrals.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
A shallow flow channel carries an oil-in-water emulsion between electrodes mounted in its upper and lower walls. The voltage controller applies alternating polarity segments, each with a short higher-amplitude portion followed by a longer lower-amplitude portion. Optical cells upstream and downstream measure droplet size distributions to quantify breakup and coalescence during electrical exposure.
An electronic pressure regulator and an inline liquid flow sensor replace a pump-speed-based flow control module. The regulator pressurizes a sealed feed reservoir that supplies the shallow electrode channel, and a feedback loop adjusts reservoir pressure to hold the measured flow at its setpoint. The voltage controller enables the bipolar waveform after the sensor reports stable flow and disables it when flow drops below the set threshold.
Two interchangeable cartridges use 5 mm wide, 20 mm long channels with heights of 100 and 250 micrometers. Each cartridge has opposed electrode plates, and an acellular test liquid flows through each cartridge in turn at 0.5 and 1.0 milliliters per minute. Pressure taps immediately before and after the channel measure the pressure drop at each flow setting with the electrodes disconnected.
An automated rinse station supplies rinse liquid to the channel, and a valve directs the outlet to waste. A break-before-make relay switches the opposed electrodes from the bipolar drive circuit to a low-amplitude alternating-current impedance meter after the drive output is disabled and discharged. The meter records impedance during the final rinse and compares it with a clean-cartridge baseline at the same rinse temperature.
A light source and photodiode face each other across a transparent inlet section immediately upstream of the electrodes. The controller compares the photodiode signal with a liquid-filled baseline and inhibits the voltage output when the deviation exceeds a preset threshold for consecutive samples. The flow module continues moving liquid through the channel, and the voltage output remains inhibited until the optical signal returns to its baseline band for a preset interval.
An isolated differential voltage probe measures the signal across the opposed electrodes, and the controller samples it using the waveform trigger as a timing reference. Software measures the amplitude and duration of both portions in each polarity segment and compares each measurement with its corresponding portion in the reversed segment. The controller disables the drive after a preset number of consecutive cycles outside tolerance and stores the measured waveform with the fault record.
A constant-head reservoir supplies a steady hydrostatic pressure, and a narrow inlet capillary sets the hydraulic resistance. A separate pulse generator applies the voltage waveform as the suspension passes through the electrode region.
A polymer film with a rectangular cutout sits between two glass plates. A 50-micrometer film and a 1-millimeter-wide cutout give a channel height-to-width ratio of 0.05.
A patterned platinum film on the channel ceiling faces a matching film on the floor. The overlap defines the active region, and insulated traces connect the films to the voltage driver.
An upstream flow sensor supplies measurements to a feedback controller that adjusts pump speed to hold the selected flow rate. A separate timing circuit drives the electrode voltage waveform while liquid flows through the active region.
A digital timer commands a short interval at a higher voltage magnitude followed by a longer interval at a lower magnitude of the same polarity. A transistor bridge repeats the two durations and magnitudes with both signs reversed in the next segment.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
Accordingly, a method for isolating or identifying a circulating tumor cell comprises the steps of providing a cell suspension; passing the solution through a microfluidic channel that includes a constriction, the constriction being sized to preferentially deform a circulating tumor cell compared to a leukocyte; passing the cell suspension through the constriction; and contacting the cell suspension solution with a detectable marker.A · US 2016/0193605 A1 · ¶ 12
Preferably, the cells flow through the microfluidic channel suspended in a liquid medium that is pressure driven through the system. When a cell passes through the constriction, its membrane is perturbed causing temporary disruptions in the membrane and resulting in the uptake of the payload that is present in the surrounding media.B · US 10,526,573 B2 · ¶ 126
In some embodiments, electrodes are located on both sides of the device, e.g., on or in the top and the bottom plate or wafer.B · US 10,526,573 B2 · ¶ 106
A speed of the cells traversing a constriction can range from 10 mm/s to 10 m/s. A pressure can be applied to the cell suspension to drive cells through the constriction of a microfluidic channel.A · US 2016/0193605 A1 · ¶ 22
In an example operation, cells can be driven through the constriction channels 105 at constant pressure (5 psi-100 psi). The cells are then contacted with a pulsed electric field driven by a function generator.B · US 10,526,573 B2 · ¶ 109
An empty cell means only that no passage was reproduced there.
Existing technologies that rely on nanoparticles, electrical fields, pore-forming chemicals, etc. are capable of delivering some materials to certain cell types but often in an indiscriminant fashion with regards to the physical properties of the target cell.A · US 2016/0193605 A1 · ¶ 4
By developing selective delivery methods dependent on the physical properties of the target cells, one could exert more robust control in delivery activity for research, diagnostic or therapeutic applications.A · US 2016/0193605 A1 · ¶ 4
Technologies that can directly send payloads into cells and cell organelles are needed.B · US 10,526,573 B2 · ¶ 5
The combination of cell-deforming constriction and subsequent exposure of a cell to an energy field such as those described above leads to a synergistic effect in the delivery of cargo molecules into the cells and/or translocation of cargo molecules inside the cell to subcellular structures such as the nucleus or mitochondria.B · US 10,526,573 B2 · ¶ 6
patent.fyi, US 2026/0357184 A1, claim 1, first published 2026-11-20T11:28:11-05:00, https://patent.fyi/US20260357184/, SHA-256 bca4b00410fcbdcbf2344e685149fac17fb6efd6971d055e75a35174fc942e31